| Endocrine disrupting chemicals in fish: developing exposure indicators and predictive models of effects based on mechanism of action GT Ankley, DC Bencic, MS Breen, TW Collette, RB Conolly, ND Denslow, ... Aquatic Toxicology 92 (3), 168-178, 2009 | 314 | 2009 |
| Nonmonotonic dose-response relationships: mechanistic basis, kinetic modeling, and implications for risk assessment RB Conolly, WK Lutz Toxicological Sciences 77 (1), 151-157, 2004 | 283 | 2004 |
| Modeling interindividual variation in physiological factors used in PBPK models of humans PS Price, RB Conolly, CF Chaisson, EA Gross, JS Young, ET Mathis, ... Critical reviews in toxicology 33 (5), 469-503, 2003 | 276 | 2003 |
| Arsenic-Induced Carcinogenesis Oxidative Stress as a Possible Mode of Action and Future Research Needs for More Biologically Based Risk Assessment KT Kitchin, R Conolly Chemical research in toxicology 23 (2), 327-335, 2010 | 231 | 2010 |
| Development of a physiologically based pharmacokinetic model for chloroform RA Corley, AL Mendrala, FA Smith, DA Staats, ML Gargas, RB Conolly, ... Toxicology and applied pharmacology 103 (3), 512-527, 1990 | 211 | 1990 |
| Quantitative adverse outcome pathways and their application to predictive toxicology RB Conolly, GT Ankley, WY Cheng, ML Mayo, DH Miller, EJ Perkins, ... Environmental science & technology 51 (8), 4661-4672, 2017 | 189 | 2017 |
| Computational toxicology—a state of the science mini review RJ Kavlock, G Ankley, J Blancato, M Breen, R Conolly, D Dix, K Houck, ... Toxicological sciences 103 (1), 14-27, 2008 | 188 | 2008 |
| Chemically induced cell proliferation in carcinogenesis. BE Butterworth, JA Popp, RB Conolly, TL Goldsworthy IARC Scientific Publications, 279-305, 1992 | 180 | 1992 |
| Effect of 18 hr fast and glutathione depletion on 1, 1-dichloroethylene-induced hepatotoxicity and lethality in rats RJ Jaeger, RB Conolly, SD Murphy Experimental and molecular pathology 20 (2), 187-198, 1974 | 179 | 1974 |
| Dose-dependent transitions in mechanisms of toxicity W Slikker Jr, ME Andersen, MS Bogdanffy, JS Bus, SD Cohen, ... Toxicology and Applied Pharmacology 201 (3), 203-225, 2004 | 174 | 2004 |
| Dose-dependent transitions in mechanisms of toxicity: case studies W Slikker Jr, ME Andersen, MS Bogdanffy, JS Bus, SD Cohen, ... Toxicology and applied pharmacology 201 (3), 226-294, 2004 | 173 | 2004 |
| Diurnal variation of hepatic glutathione concentration and its correlation with 1, 1-dichloroethylene inhalation toxicity in rats RJ Jaeger, RB Conolly, SD Murphy Res. Commun. Chem. Pathol. Pharmacol 6 (2), 465-47, 1973 | 168 | 1973 |
| A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments BE Butterworth, RB Conolly, KT Morgan Cancer letters 93 (1), 129-146, 1995 | 166 | 1995 |
| Human respiratory tract cancer risks of inhaled formaldehyde: dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and … RB Conolly, JS Kimbell, D Janszen, PM Schlosser, D Kalisak, J Preston, ... Toxicological Sciences 82 (1), 279-296, 2004 | 158 | 2004 |
| Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling RH Reitz, AL Mendrala, RA Corley, JF Quast, ML Gargas, ME Andersen, ... Toxicology and applied pharmacology 105 (3), 443-459, 1990 | 149 | 1990 |
| Building and applying quantitative adverse outcome pathway models for chemical hazard and risk assessment EJ Perkins, R Ashauer, L Burgoon, R Conolly, B Landesmann, C Mackay, ... Environmental Toxicology and Chemistry 38 (9), 1850-1865, 2019 | 127 | 2019 |
| Ototoxicity of toluene in rats MJ Sullivan, KE Rarey, RB Conolly Neurotoxicology and teratology 10 (6), 525-530, 1988 | 123 | 1988 |
| Biologically motivated computational modeling of formaldehyde carcinogenicity in the F344 rat RB Conolly, JS Kimbell, D Janszen, PM Schlosser, D Kalisak, J Preston, ... Toxicological Sciences 75 (2), 432-447, 2003 | 115 | 2003 |
| Biologically based pharmacodynamic models: tools for toxicological research and risk assessment RB Conolly, ME Andersen Annual Review of Pharmacology and Toxicology 31 (1), 503-523, 1991 | 115 | 1991 |
| Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropyfluorophosphate JM Gearhart, GW Jepson, HJ Clewell III, ME Andersen, RB Conolly Toxicology and applied pharmacology 106 (2), 295-310, 1990 | 106 | 1990 |
Melvin E. AndersenScitoVation LLCVerified email at scitovation.com
